Approaches to Authenticating Products Containing Red Yeast Rice Extract (Monacolin K).
Level 5 - mechanism / opinion, no new human data
Narrative review of analytical methods and supplement quality issues without clinical trial data.
PubMed 41752500 · doi:10.3390/molecules31040723
What was done
The authors conducted a narrative review of the chemical composition, safety issues, regulatory challenges, and quality concerns of red yeast rice food supplements. They proposed a multi-tiered analytical strategy combining targeted quantification of monacolin K and related monacolins, identification of Monascus pigment markers, gas chromatography-mass spectrometry, and proton nuclear magnetic resonance fingerprinting to authenticate products and identify undeclared pharmaceutical adulterants.
What was found
No quantitative results, detection limits, or statistical data were reported in the abstract. The authors described a conceptual combined workflow of targeted and non-targeted chemical assays to address the challenge of differentiating natural monacolin K from synthetic lovastatin and other adulterants.
Why it matters
Monacolin K is chemically identical to prescription lovastatin, making quality control and detection of synthetic adulteration in dietary supplements difficult. A comprehensive multi-method analytical workflow can help standardize quality assurance and protect consumers.
Limits
As a narrative review, the abstract provides no primary empirical testing data, sample sizes of evaluated commercial products, or comparative accuracy metrics for the proposed analytical workflow.
Cited by
- supports Red yeast rice contains the active chemical ingredient of early statin pharmaceuticals (monacolin).